玉林YULIN品牌怎么样 申请店铺

我要投票 玉林YULIN在医疗器械行业中的票数:11 更新时间:2024-11-22
玉林YULIN是哪个国家的品牌?「玉林YULIN」是 广西玉林制药集团有限责任公司 旗下著名品牌。该品牌发源于广西玉林市,由创始人高海恩在1985-11-28期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
玉林YULIN怎么样

始于1956年,康臣药业集团旗下,中华老字号,拥有正骨水/湿毒清胶囊/鸡骨草胶囊/云香精/三七伤药胶等知名药品,以中药为主,生产胶囊剂/酊剂等药物的高新技术企业


广西玉林制药集团是康臣药业集团(1681.HK)的成员企业之一,前身为创立于1956年的玉林制药厂,是一家以中成药和天然药物研发、生产、销售为主业的中药制药企业。玉林制药的业务已拓展到中药饮片加工、中药材种植与经营、药用空心胶囊制造、国内国际贸易等领域。

公司主要产品有正骨水、湿毒清胶囊、鸡骨草胶囊、云香精、银蒲解毒片、珍黄胶囊(珍黄丸)、三七伤药胶囊等9个剂型74个品种,其中国家中药保护品种有正骨水、湿毒清胶囊、鸡骨草胶囊等12个品种。公司产品质量可靠,疗效确切,品牌知名度高。

公司拥有强大的中药综合处理及制剂能力,其中胶囊剂18.5亿粒/年,片剂7.6亿片/年,酊剂76万升/年。拥有健全的质量保障体系,于1996年通过澳大利亚TGA的GMP认证,并连续八次通过复查,2003年整体通过国家GMP认证。

公司产销规模达5亿多元,经营稳健。公司具有自营进出口权,出口产品50种,远销30多个国家和地区,年出口创汇近300万美元。

公司始终坚持以市场为导向,项目为载体,加强产学研的联合,具备良好的产品研发能力和对外技术合作基础,拥有各类专业人员360多人。

长期以来,玉林制药始终秉承“珍爱生命、关注健康”的经营宗旨,为人类创造健康、为股东创造利益、为员工创造前途、为社会创造效益。作为康臣药业集团的成员企业,玉林制药将不断丰富和优化产品结构,强化质量控制,创新产品研发和营销模式,与客户合作共赢。


In 1956, the Chinese time-honored brand of Kang Chen Pharmaceutical Group has the famous medicines such as bone setting water / damp poison capsule / chicken bone grass capsule / cloud essence / 37 adhesive, etc. the high-tech pharmaceutical enterprise, which is mainly traditional Chinese medicine, produces capsules / tincture, and so on. The Guangxi Yulin Pharmaceutical Group is one of the members of Kang Chen Pharmaceutical Group (1681.HK), formerly known as the Yulin pharmaceutical factory founded in 1956. Is a traditional Chinese medicine pharmaceutical enterprise with R & D, production and sales of proprietary Chinese medicine and natural medicine as its main business. Yulin pharmaceutical's business has expanded to the processing of Chinese herbal pieces, the planting and management of Chinese herbal medicines, the manufacturing of medicinal hollow capsules, domestic and international trade and other fields. The main products of China are 74 kinds of 9 formulations: "bone setting water", "damp poison capsule", "chicken bone grass capsule", "Yun Xiang essence", "yinpu Jiedu Tablets", "Zhen Huang capsule" (Zhen Huang pill), and "37 capsule". Among them, 12 kinds of Chinese medicine protection varieties are bone setting water, damp poison capsule, chicken bone grass capsule and so on. The company has reliable product quality, precise curative effect and high brand awareness. The company has strong comprehensive treatment and preparation capacity of traditional Chinese medicine, including 1.85 billion capsules / year, 76000 tablets / year and 760000 tinctures / year. It has a sound quality assurance system, passed the GMP certification of TGA in Australia in 1996, passed the review eight times in succession, and passed the national GMP certification as a whole in 2003. The production and marketing scale of the company is more than 500 million yuan, and the operation is stable. The company has the right of self import and export, 50 kinds of export products, exported to more than 30 countries and regions, with an annual export earning of nearly 3 million US dollars. The company always adheres to the market-oriented, project-based, strengthening the combination of production, learning and research, with good product R & D capabilities and foreign technical cooperation foundation, with more than 360 professionals. For a long time, Yulin pharmaceutical has always adhered to the business tenet of "cherish life and pay attention to health", creating health for human beings, interests for shareholders, future for employees and benefits for society. As a member enterprise of Kangchen Pharmaceutical Group, Yulin pharmaceutical will continue to enrich and optimize product structure, strengthen quality control, innovate product R & D and marketing mode, and cooperate with customers for win-win results.

本文链接: https://brand.waitui.com/b4dba7440.html 联系电话:07753892003

千城特选小程序码

7×24h 快讯

比亚迪否认与蔚来汽车成立合资公司

11月22日,比亚迪集团品牌及公关处总经理李云飞表示,网传比亚迪与蔚来汽车相关的投资及合作信息,为严重不实信息。今日网络有传言称,比亚迪与蔚来将合作成立比未来汽车集团。(第一财经)

34分钟前

亚马逊明年或面临欧盟《数字市场法案》相关调查

据路透消息,知情人士称,亚马逊明年可能面临欧盟《数字市场法案》(DMA)相关调查,涉及该公司是否于其在线市场上偏袒自有品牌产品。据透露,欧盟即将上任的反垄断负责人特雷莎·里韦拉(Teresa Ribera)将在未来几个月内决定是否启动调查。里韦拉将于下月上任,接替即将离任的玛格丽特·维斯塔格。(界面)

34分钟前

电投产融:拟投建国家电投大连市花园口Ⅰ、Ⅱ海上风电项目

36氪获悉,电投产融发布公告,国家电投大连市花园口Ⅰ海上风电项目于2024年1月30日取得大连市发展和改革委员会核准批复意见,拟于近期开工建设,项目总投资18.98亿元。国家电投大连市花园口Ⅱ海上风电项目于2023年11月10日取得大连市发展和改革委员会核准批复意见,拟于近期开工建设,项目总投资21.81亿元。

34分钟前

中国证券业协会召开股权与另类投资业务专业委员会全体会议

2024年11月14日,中国证券业协会在江苏南京召开股权与另类投资业务专业委员会全体会议。会议强调,行业机构要认真履职,树立并坚持理性投资、价值投资、长期投资的理念,以契合金融“五篇大文章”为主要目标选择投资标的,发挥证券公司在创业投资和私募股权投资方面的主力军、排头兵作用,加强投资过程管理,注重维护和保障投资者的利益,避免资金“脱实向虚”,为推动实体经济发展、优化资源配置、支持科技创新等做出更大贡献。(证券时报)

34分钟前

DHL快递与壳牌签署合作协议

11月22日,DHL快递宣布与壳牌(Shell)签署协议,这项为期一年的协议包括通过输送管道向布鲁塞尔机场运送2.5万吨经国际可持续发展和碳认证(International Sustainability and Carbon Certification,即ISCC)体系认证的可持续航空燃料。(界面)

34分钟前

本页详细列出关于诚益通的品牌信息,含品牌所属公司介绍,诚益通所处行业的品牌地位及优势。
咨询